MedX Health Corp. Advances Private Placement to Boost Telemedicine Platform

The latest update is out from MedX Health ( (TSE:MDX) ).

MedX Health Corp. has announced the further closing of its non-brokered private placement, raising an additional $511,000 and bringing the total funds raised to $1,456,000. The proceeds will support the development of its SIAscopy® on DermSecure® platform and its expansion into the occupational health market. The company aims to raise a maximum of $2,500,000 through this placement, with future closings subject to regulatory approvals. This financial move is expected to bolster MedX’s market positioning and operational capabilities.

More about MedX Health

MedX Health Corp., based in Ontario, Canada, is a prominent medical device and software company specializing in skin health. It offers the SIAscopy® on DermSecure® telemedicine platform, which uses patented technology to provide non-invasive, real-time imaging of skin moles and lesions. MedX’s products, including SIAMETRICS®, SIMSYS®, and MoleMate®, are approved for use in several countries, including Canada, the U.S., and the European Union.

Average Trading Volume: 107,193

Technical Sentiment Signal: Buy

Current Market Cap: C$21.44M

For detailed information about MDX stock, go to TipRanks’ Stock Analysis page.